{"id":"https://openalex.org/W2323968754","doi":"https://doi.org/10.1021/acs.jmedchem.5b00054","title":"Identification of GDC-0810 (ARN-810), an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) that Demonstrates Robust Activity in Tamoxifen-Resistant Breast Cancer Xenografts","display_name":"Identification of GDC-0810 (ARN-810), an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) that Demonstrates Robust Activity in Tamoxifen-Resistant Breast Cancer Xenografts","publication_year":2015,"publication_date":"2015-04-16","ids":{"openalex":"https://openalex.org/W2323968754","doi":"https://doi.org/10.1021/acs.jmedchem.5b00054","mag":"2323968754","pmid":"https://pubmed.ncbi.nlm.nih.gov/25879485"},"language":"en","primary_location":{"id":"doi:10.1021/acs.jmedchem.5b00054","doi":"https://doi.org/10.1021/acs.jmedchem.5b00054","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.5b00054","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065142951","display_name":"Andiliy G. Lai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andiliy Lai","raw_affiliation_strings":["Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mehmet Kahraman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mehmet Kahraman","raw_affiliation_strings":["Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059378712","display_name":"Steven P. Govek","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven Govek","raw_affiliation_strings":["Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021286275","display_name":"Johnny Y. Nagasawa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Johnny Nagasawa","raw_affiliation_strings":["Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072118690","display_name":"C\u00e9line Bonnefous","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Celine Bonnefous","raw_affiliation_strings":["Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032042452","display_name":"Jackie Julien","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jackie Julien","raw_affiliation_strings":["Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007455917","display_name":"Karensa L. Douglas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karensa Douglas","raw_affiliation_strings":["Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006915014","display_name":"John Sensintaffar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Sensintaffar","raw_affiliation_strings":["Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035337955","display_name":"Nhin Lu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nhin Lu","raw_affiliation_strings":["Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028277613","display_name":"Kyoung\u2010Jin Lee","orcid":"https://orcid.org/0009-0004-4288-9239","observed_orcids":["https://orcid.org/0009-0004-4288-9239"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kyoung-jin Lee","raw_affiliation_strings":["Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050565684","display_name":"Anna M. Aparicio","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Aparicio","raw_affiliation_strings":["Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108468666","display_name":"Josh Kaufman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Josh Kaufman","raw_affiliation_strings":["Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001637232","display_name":"Jing Qian","orcid":"https://orcid.org/0000-0001-6120-5147","observed_orcids":["https://orcid.org/0000-0001-6120-5147"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jing Qian","raw_affiliation_strings":["Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100518237","display_name":"Gang Shao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gang Shao","raw_affiliation_strings":["Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006279759","display_name":"Rene Y. Prudente","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rene Prudente","raw_affiliation_strings":["Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008557181","display_name":"Michael Jongho Moon","orcid":"https://orcid.org/0000-0001-9997-5817","observed_orcids":["https://orcid.org/0000-0001-9997-5817"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael J. Moon","raw_affiliation_strings":["Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037379407","display_name":"James D. Joseph","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James D. Joseph","raw_affiliation_strings":["Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012291117","display_name":"Beatrice D. Darimont","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Beatrice Darimont","raw_affiliation_strings":["Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087085239","display_name":"Daniel Brigham","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Brigham","raw_affiliation_strings":["Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024913625","display_name":"Kate Grillot","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kate Grillot","raw_affiliation_strings":["Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014567706","display_name":"Richard A. Heyman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard Heyman","raw_affiliation_strings":["Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077906047","display_name":"Peter J. Rix","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter J. Rix","raw_affiliation_strings":["Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079488873","display_name":"Jeffrey H. Hager","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey H. Hager","raw_affiliation_strings":["Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102820332","display_name":"Nicholas D. Smith","orcid":"https://orcid.org/0000-0001-5791-8849","observed_orcids":["https://orcid.org/0000-0001-5791-8849"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Nicholas D. Smith","raw_affiliation_strings":["Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, \u2021Department of Biology, \u00a7Department of Drug\rSafety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5102820332"],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":19.1108,"has_fulltext":false,"cited_by_count":261,"citation_normalized_percentile":{"value":0.99881165,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"58","issue":"12","first_page":"4888","last_page":"4904"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.015799999237060547,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/selective-estrogen-receptor-degrader","display_name":"selective estrogen receptor degrader","score":0.9269999861717224},{"id":"https://openalex.org/keywords/estrogen-receptor-alpha","display_name":"estrogen receptor alpha","score":0.8560000061988831},{"id":"https://openalex.org/keywords/tamoxifen-resistance","display_name":"tamoxifen resistance","score":0.9909999966621399},{"id":"https://openalex.org/keywords/estrogen-receptor-positive-breast-cancer","display_name":"estrogen receptor-positive breast cancer","score":0.8949999809265137},{"id":"https://openalex.org/keywords/orally-bioavailable-drugs","display_name":"orally bioavailable drugs","score":0.7699999809265137},{"id":"https://openalex.org/keywords/fulvestrant","display_name":"fulvestrant","score":0.8119999766349792},{"id":"https://openalex.org/keywords/breast-cancer-xenografts","display_name":"breast cancer xenografts","score":0.8050000071525574},{"id":"https://openalex.org/keywords/drug-discovery","display_name":"drug discovery","score":0.48500001430511475}],"concepts":[{"id":"https://openalex.org/C2780482068","wikidata":"https://www.wikidata.org/wiki/Q5508491","display_name":"Fulvestrant","level":5,"score":0.9505667686462402},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.8292127847671509},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.7766646146774292},{"id":"https://openalex.org/C172313692","wikidata":"https://www.wikidata.org/wiki/Q14902310","display_name":"Estrogen receptor alpha","level":5,"score":0.651982843875885},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6436359882354736},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.532249927520752},{"id":"https://openalex.org/C2776067312","wikidata":"https://www.wikidata.org/wiki/Q50429983","display_name":"Antiestrogen","level":5,"score":0.5220556259155273},{"id":"https://openalex.org/C2776166826","wikidata":"https://www.wikidata.org/wiki/Q415287","display_name":"Aromatase","level":4,"score":0.5200590491294861},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5147883892059326},{"id":"https://openalex.org/C2777944059","wikidata":"https://www.wikidata.org/wiki/Q903917","display_name":"Selective estrogen receptor modulator","level":5,"score":0.48944607377052307},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4627402424812317},{"id":"https://openalex.org/C96307122","wikidata":"https://www.wikidata.org/wiki/Q15329133","display_name":"Estrogen receptor beta","level":5,"score":0.4453490972518921},{"id":"https://openalex.org/C2777164284","wikidata":"https://www.wikidata.org/wiki/Q277954","display_name":"Estrogen","level":2,"score":0.4199202060699463},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.41761288046836853},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3397131860256195},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2519969940185547}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001940","descriptor_name":"Breast","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001940","descriptor_name":"Breast","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001940","descriptor_name":"Breast","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013629","descriptor_name":"Tamoxifen","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D020845","descriptor_name":"Selective Estrogen Receptor Modulators","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047628","descriptor_name":"Estrogen Receptor alpha","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054852","descriptor_name":"Small Molecule Libraries","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D054852","descriptor_name":"Small Molecule Libraries","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D054852","descriptor_name":"Small Molecule Libraries","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D054852","descriptor_name":"Small Molecule Libraries","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059748","descriptor_name":"Proteolysis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D064593","descriptor_name":"Heterografts","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/acs.jmedchem.5b00054","doi":"https://doi.org/10.1021/acs.jmedchem.5b00054","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.5b00054","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:25879485","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25879485","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W1967402374","https://openalex.org/W1982648471","https://openalex.org/W1984555480","https://openalex.org/W2013956549","https://openalex.org/W2016908879","https://openalex.org/W2021145743","https://openalex.org/W2023586989","https://openalex.org/W2036089268","https://openalex.org/W2036673057","https://openalex.org/W2037460676","https://openalex.org/W2048624904","https://openalex.org/W2054073416","https://openalex.org/W2056155028","https://openalex.org/W2057665005","https://openalex.org/W2060011282","https://openalex.org/W2062458432","https://openalex.org/W2063712126","https://openalex.org/W2071164190","https://openalex.org/W2073367400","https://openalex.org/W2075221169","https://openalex.org/W2087553857","https://openalex.org/W2089595068","https://openalex.org/W2109541969","https://openalex.org/W2112577860","https://openalex.org/W2116890833","https://openalex.org/W2117634794","https://openalex.org/W2122148679","https://openalex.org/W2124358769","https://openalex.org/W2131394541","https://openalex.org/W2136673273","https://openalex.org/W2153169044","https://openalex.org/W2156009048","https://openalex.org/W2173050085","https://openalex.org/W4254152438"],"related_works":["https://openalex.org/W2886595387","https://openalex.org/W2563294220","https://openalex.org/W2886595719","https://openalex.org/W3084846649","https://openalex.org/W2012767871","https://openalex.org/W2986619859","https://openalex.org/W2019311111","https://openalex.org/W2886333171","https://openalex.org/W4254025557","https://openalex.org/W2591829219"],"abstract_inverted_index":{"Approximately":[0],"80%":[1],"of":[2,33,112,134,137,148,172],"breast":[3,176,193],"cancers":[4],"are":[5,143],"estrogen":[6,72,191],"receptor":[7,73,126],"alpha":[8],"(ER-\u03b1)":[9],"positive,":[10],"and":[11,24,79,82,100,118,132,146,150,174,178],"although":[12],"women":[13,185],"typically":[14],"initially":[15],"respond":[16],"well":[17],"to":[18,63,121],"antihormonal":[19,91],"therapies":[20],"such":[21],"as":[22],"tamoxifen":[23],"aromatase":[25],"inhibitors,":[26],"resistance":[27,34],"often":[28],"emerges.":[29],"Although":[30],"a":[31,54,69,135],"variety":[32],"mechanism":[35],"may":[36],"be":[37,102,116],"at":[38],"play":[39],"in":[40,47,59,85,151,170,181,184],"this":[41],"state,":[42],"there":[43],"is":[44,68,83,179],"evidence":[45],"that":[46,76,107,114],"many":[48],"cases":[49],"the":[50,60,109,122,130,153],"ER":[51,61],"still":[52],"plays":[53],"central":[55],"role,":[56],"including":[57],"mutations":[58],"leading":[62],"constitutively":[64],"active":[65,84],"receptor.":[66],"Fulvestrant":[67],"steroid-based,":[70],"selective":[71],"degrader":[74],"(SERD)":[75],"both":[77],"antagonizes":[78],"degrades":[80],"ER-\u03b1":[81,149,154],"patients":[86],"who":[87],"have":[88],"progressed":[89],"on":[90],"agents.":[92],"However,":[93],"fulvestrant":[94],"suffers":[95],"from":[96],"poor":[97],"pharmaceutical":[98],"properties":[99,156],"must":[101],"administered":[103,117],"by":[104],"intramuscular":[105],"injections":[106],"limit":[108],"total":[110],"amount":[111],"drug":[113],"can":[115],"hence":[119],"lead":[120,161],"potential":[123],"for":[124],"incomplete":[125],"blockade.":[127],"We":[128],"describe":[129],"identification":[131],"characterization":[133],"series":[136],"small-molecule,":[138],"orally":[139],"bioavailable":[140],"SERDs":[141],"which":[142,152],"potent":[144],"antagonists":[145],"degraders":[147],"degrading":[155],"were":[157],"prospectively":[158],"optimized.":[159],"The":[160],"compound":[162],"11l":[163],"(GDC-0810":[164],"or":[165,189],"ARN-810)":[166],"demonstrates":[167],"robust":[168],"activity":[169],"models":[171],"tamoxifen-sensitive":[173],"tamoxifen-resistant":[175],"cancer,":[177],"currently":[180],"clinical":[182],"trials":[183],"with":[186],"locally":[187],"advanced":[188],"metastatic":[190],"receptor-positive":[192],"cancer.":[194]},"counts_by_year":[{"year":2026,"cited_by_count":10},{"year":2025,"cited_by_count":19},{"year":2024,"cited_by_count":17},{"year":2023,"cited_by_count":25},{"year":2022,"cited_by_count":18},{"year":2021,"cited_by_count":21},{"year":2020,"cited_by_count":27},{"year":2019,"cited_by_count":26},{"year":2018,"cited_by_count":33},{"year":2017,"cited_by_count":25},{"year":2016,"cited_by_count":28},{"year":2015,"cited_by_count":12}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}